| Data | Hora | Fonte | Título | Código | Companhia |
| 11/07/2016 | 17:23 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 05/07/2016 | 18:02 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 30/06/2016 | 07:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 24/06/2016 | 16:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 24/06/2016 | 10:34 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 24/06/2016 | 10:27 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 24/06/2016 | 10:24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 24/06/2016 | 10:23 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 24/06/2016 | 10:22 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 24/06/2016 | 10:21 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 10/06/2016 | 11:55 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 31/05/2016 | 07:00 | Dow Jones News | Jazz Pharmaceuticals Agrees to Buy Celator for About $1.5 Billion | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 30/05/2016 | 23:50 | Dow Jones News | Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 30/05/2016 | 23:49 | Dow Jones News | Correction to Jazz Pharmaceuticals Story | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 26/05/2016 | 15:07 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 26/05/2016 | 14:49 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 20/05/2016 | 23:10 | Business Wire | SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Anacor Pharmaceuticals, Inc. | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 20/05/2016 | 17:43 | Business Wire | INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into Whether the Sale of Anacor Pharmaceuticals, Inc. to Pfizer... | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 20/05/2016 | 15:08 | Business Wire | ANACOR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Anacor Pharmaceuticals, Inc. (ANAC) Over the P... | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 20/05/2016 | 09:10 | PR Newswire (US) | Are These Biotech Stocks Prescribed for Investors' Portfolio? - Anacor Pharma, Athersys, Aralez Pharma and Infinity Pharma | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 19/05/2016 | 23:10 | PR Newswire (US) | SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Anacor Pharmaceuticals, Inc. -AN... | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 19/05/2016 | 17:37 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 19/05/2016 | 14:33 | Business Wire | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Regarding the Fairness of the Sale of Anacor Pharmaceuticals... | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 18/05/2016 | 17:28 | Business Wire | Anacor Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Merger with Pfiz... | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 18/05/2016 | 11:41 | PR Newswire (US) | Ryan & Maniskas, LLP Announces Investigation of Anacor Pharmaceuticals, Inc. | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 17/05/2016 | 18:02 | Business Wire | INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Anacor Pharmaceuticals, Inc. & Encourages I... | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 17/05/2016 | 15:44 | PR Newswire (US) | INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of Anacor Pharmaceuticals, ... | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 17/05/2016 | 14:26 | PR Newswire (US) | Block & Leviton LLP Investigates Anacor Pharmaceuticals Inc., Inc. for Possible Breaches of Fiduciary Duty in Connection with... | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 17/05/2016 | 04:06 | Dow Jones News | Pfizer Buys Anacor In Turn to Smaller Deals -- WSJ | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
| 16/05/2016 | 19:17 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |